https://sputnikglobe.com/20210619/sputnik-light-boosts-antibodies-against-all-covid-strains-during-revaccination-developer-says-1083187882.html
Sputnik Light Boosts Antibodies Against All COVID Strains During Revaccination, Developer Says
Sputnik Light Boosts Antibodies Against All COVID Strains During Revaccination, Developer Says
Sputnik International
MOSCOW (Sputnik) - Sputnik Light COVID-19 vaccine can be used for revaccination, which will increase the level of antibodies against all circulating strains... 19.06.2021, Sputnik International
2021-06-19T06:24+0000
2021-06-19T06:24+0000
2021-06-19T06:24+0000
https://cdn1.img.sputnikglobe.com/img/07e5/01/0c/1081740575_14:0:3000:1688_1920x0_80_0_0_9bd067abe6744d1aada3793e64535fcd.jpg
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, coronavirus, gamaleya research institute of epidemiology and microbiology, alexander gintsburg
newsfeed, coronavirus, gamaleya research institute of epidemiology and microbiology, alexander gintsburg
Sputnik Light Boosts Antibodies Against All COVID Strains During Revaccination, Developer Says
MOSCOW (Sputnik) - Sputnik Light COVID-19 vaccine can be used for revaccination, which will increase the level of antibodies against all circulating strains, Alexander Gintsburg, the chief of the Russian Gamaleya Research Centre, told Sputnik.
"Revaccination with 'Sputnik V' can be done. There are absolutely no problems. Currently, the so-called single-component version of the vaccine, 'Sputnik Light,' is registered. It is registered, among other things, in order to raise the level of antibodies after illness or some time after vaccination", Gintsburg said.
The Gamaleya chief added that the revaccination with Sputnik Light would develop antibodies against all existing COVID-19 variants.
The slimmed-down version of the vaccine was registered in late March as an alternative to the main two-shot Sputnik V after successfully undergoing all three phases of clinical trials. The latter remains the main option for export and internal use in the country.
